Literature DB >> 20702066

Stability of doripenem, imipenem and meropenem at elevated room temperatures.

Rebecca A Keel, Christina A Sutherland, Jared L Crandon, David P Nicolau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20702066     DOI： 10.1016/j.ijantimicag.2010.06.043

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  14 in total

Review 1.  Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.

Authors:  Stephen John Perks; Cassie Lanskey; Niechole Robinson; Tilley Pain; Richard Franklin
Journal:  Eur J Hosp Pharm       Date:  2019-06-20

2.  Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

3.  Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.

Authors:  Phillip J Bergen; Alan Forrest; Jürgen B Bulitta; Brian T Tsuji; Hanna E Sidjabat; David L Paterson; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

4.  Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.

Authors:  William A Prescott; Allison E Gentile; Jerod L Nagel; Rebecca S Pettit
Journal:  P T       Date:  2011-11

5.  Determination of meropenem in bacterial media by LC-MS/MS.

Authors:  Liusheng Huang; Janus Haagensen; Davide Verotta; Patricia Lizak; Francesca Aweeka; Katherine Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-14       Impact factor: 3.205

6.  Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Phillip J Bergen; Brian T Tsuji; Jurgen B Bulitta; Alan Forrest; Jovan Jacob; Hanna E Sidjabat; David L Paterson; Roger L Nation; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

7.  Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.

Authors:  Dong-Hwan Lee; Yong Kyun Kim; Kyubok Jin; Myoung Joo Kang; Young-Don Joo; Yang Wook Kim; Young Soo Moon; Jae-Gook Shin; Sungmin Kiem
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

8.  Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.

Authors:  Vanessa E Rees; Rajbharan Yadav; Kate E Rogers; Jürgen B Bulitta; Veronika Wirth; Antonio Oliver; John D Boyce; Anton Y Peleg; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

9.  A Natural Deep Eutectic Solvent Formulated to Stabilize β-Lactam Antibiotics.

Authors:  Belén Olivares; Fabián Martínez; Lina Rivas; Cristian Calderón; José M Munita; Paola R Campodonico
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

10.  Pharmacokinetics of Doripenem in Healthy Koreans and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients With Normal and Enhanced Renal Function.

Authors:  So Won Kim; Sangmin Choe; Dong Jin Kim; Dae Young Zang; Dong-Hwan Lee
Journal:  Ther Drug Monit       Date:  2018-08       Impact factor: 3.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.